139 related articles for article (PubMed ID: 33292271)
1. LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt/β-catenin pathway.
Li W; Yang G; Yang D; Li D; Sun Q
Cancer Cell Int; 2020 Nov; 20(1):543. PubMed ID: 33292271
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.
Qi Y; Shan Y; Li S; Huang Y; Guo Y; Huang T; Zhao X; Jia L
Dig Dis Sci; 2022 Jun; 67(6):2182-2194. PubMed ID: 34021424
[TBL] [Abstract][Full Text] [Related]
3.
Wang J; Liu X; Yan C; Liu J; Wang S; Hong Y; Gu A; Zhao P
Onco Targets Ther; 2017; 10():4251-4260. PubMed ID: 28894380
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
Liu DC; Song LL; Liang Q; Hao L; Zhang ZG; Han CH
J Cell Physiol; 2019 Aug; 234(8):12727-12744. PubMed ID: 30613973
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LEF1-AS1 is involved in the progression of retinoblastoma through regulating the Wnt/β-catenin pathway.
He H; Qin M
Clin Exp Pharmacol Physiol; 2020 May; 47(5):886-891. PubMed ID: 31990064
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LEF1-AS1 regulates the migration and proliferation of vascular smooth muscle cells by targeting miR-544a/PTEN axis.
Zhang L; Zhou C; Qin Q; Liu Z; Li P
J Cell Biochem; 2019 Sep; 120(9):14670-14678. PubMed ID: 31016789
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
10. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA
Tang L; Chen Y; Tang X; Wei D; Xu X; Yan F
J Cancer; 2020; 11(2):311-323. PubMed ID: 31897227
[No Abstract] [Full Text] [Related]
12. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
Liu CN; Zhang HY; Liu CL; Wang CC
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion.
Hou M; Wu N; Yao L
Cancer Cell Int; 2021 Jan; 21(1):36. PubMed ID: 33422081
[TBL] [Abstract][Full Text] [Related]
14. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
15. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA EZR-AS1 promotes tumor growth and metastasis by modulating Wnt/β-catenin pathway in breast cancer.
Bai Y; Zhou X; Huang L; Wan Y; Li X; Wang Y
Exp Ther Med; 2018 Sep; 16(3):2235-2242. PubMed ID: 30186463
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
18. lncRNA
Yang J; Lin X; Jiang W; Wu J; Lin L
DNA Cell Biol; 2019 Sep; 38(9):1013-1021. PubMed ID: 31386568
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]